Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations

Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations

Abstract Background While surgery is the first-line treatment for patients with endogenous hypercortisolism (Cushing syndrome [CS]), mifepristone has been shown to be a beneficial medical treatment option, as demonstrated in the SEISMIC (Study of the Efficacy and Safety of Mifepristone in the Treatm...

Full description

Bibliographic Details
Main Authors: David R. Brown, Honey E. East, Bradley S. Eilerman, Murray B. Gordon, Elizabeth E. King, Laura A. Knecht, Brandon Salke, Susan L. Samson, Kevin C. J. Yuen, Hanford Yau
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Clinical Diabetes and Endocrinology
Subjects:
Cushing syndrome
Drug effects
Education
Online Access:http://link.springer.com/article/10.1186/s40842-020-00105-4

Internet

http://link.springer.com/article/10.1186/s40842-020-00105-4

Similar Items